After hours:
| Previous Close | 5.12 |
| Open | 5.10 |
| Bid | 5.28 x 1000 |
| Ask | 5.33 x 2500 |
| Day's Range | 5.06 - 5.34 |
| 52 Week Range | 4.06 - 10.13 |
| Volume | |
| Avg. Volume | 3,788,345 |
| Market Cap | 1.258B |
| Beta (5Y Monthly) | 0.91 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.32 |
| Earnings Date | Feb 20, 2025 - Feb 24, 2025 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.67 |
GlobeNewswireArdelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference
WALTHAM, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that Justin Renz, Chief Financial and Operations Officer, and Eric Foster, Chief Commercial Officer, will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4, 2024 at 12:30pm
Simply Wall St.High Growth Tech Stocks To Explore In November 2024
Over the last 7 days, the United States market has dropped 2.1%, yet it remains up 30% over the past year, with earnings forecast to grow by 15% annually. In this context, identifying high growth tech stocks that align with these positive earnings forecasts can be a strategic approach for those looking to explore opportunities in November 2024.
